Global Pepsinogen Test kit Market Size By Type (Immunochromatography, Chemiluminescence Immunoassay), By Application (Hospital, Clinic), By Region, And Segment Forecasts, 2023 to 2032

The Global Pepsinogen Test Kit Market was valued at USD 690 million in 2023 and is projected to surpass USD 1.18 billion by 2031, growing at a CAGR of 7.0% during the forecast period from 2023 to 2031. The market is witnessing growth due to the rising prevalence of gastric disorders, increasing awareness about early diagnosis of stomach cancer, and the growing demand for non-invasive diagnostic tools. Pepsinogen test kits, primarily used for screening gastric mucosal atrophy and detecting early-stage gastric cancer, are gaining traction in both developed and developing regions. Technological advancements and the shift towards preventive healthcare are further fueling market demand.

Drivers

1. Rising Prevalence of Gastric Disorders

The increasing incidence of conditions such as Helicobacter pylori infection, atrophic gastritis, and stomach cancer is driving the demand for early diagnostic solutions, particularly pepsinogen test kits that offer non-invasive and cost-effective screening.

2. Focus on Early Detection of Gastric Cancer

Early-stage detection plays a critical role in improving patient outcomes in gastric cancer. Pepsinogen test kits, often used in conjunction with serum gastrin-17 testing, are becoming vital tools in population-based screening programs, especially in East Asia.

3. Growing Geriatric Population

Aging populations globally are more susceptible to gastrointestinal disorders, increasing the need for routine screenings and diagnostic evaluations such as pepsinogen testing.

Restraints

1. Limited Awareness in Low-Income Regions

Despite their clinical relevance, the adoption of pepsinogen test kits is limited in low- and middle-income countries due to a lack of awareness, inadequate healthcare infrastructure, and minimal government initiatives toward gastric cancer screening.

2. Reimbursement Challenges

In some regions, diagnostic procedures including pepsinogen testing are not covered adequately by public or private insurance schemes, restraining their widespread adoption.

Opportunity

1. Expansion in Emerging Markets

Countries in Asia-Pacific and Latin America are investing in healthcare infrastructure and cancer screening programs. This opens new growth avenues for pepsinogen test kits, especially through public health campaigns and preventive care initiatives.

2. Integration with Digital Health Platforms

The integration of pepsinogen testing with electronic health records and telehealth systems presents an opportunity for remote diagnostics, improved patient monitoring, and real-time decision-making in clinical practices.

Market by System Type Insights

Based on system type, Laboratory-Based Pepsinogen Test Kits accounted for the largest market share in 2023. These kits are extensively used in hospitals and diagnostic laboratories due to their high sensitivity and accuracy. However, Point-of-Care (PoC) Test Kits are expected to witness the fastest growth during the forecast period, fueled by the increasing preference for rapid diagnostics and decentralized healthcare delivery.

Market by End-use Insights

The Hospitals & Diagnostic Laboratories segment dominated the global market in 2023, holding over 60% of the market share. These institutions offer comprehensive diagnostic services, including pepsinogen testing as part of routine gastrointestinal evaluations. Meanwhile, Research Institutions & Clinical Studies are gaining prominence as stakeholders explore biomarkers and preventive screening methods for gastric diseases.

Market by Regional Insights

Geographically, Asia-Pacific emerged as the largest market for pepsinogen test kits in 2023, with countries like Japan, China, and South Korea leading due to government-supported gastric cancer screening programs. North America and Europe are also showing strong growth, driven by increasing investments in early diagnostics and healthcare innovation. Latin America and Middle East & Africa are anticipated to register significant growth during the forecast period due to expanding healthcare access and awareness initiatives.

Competitive Scenario

Prominent players in the global pepsinogen test kit market include Eiken Chemical Co., Ltd., Biohit Oyj, Abbott Laboratories, Zhejiang Orient Gene Biotech Co., Ltd., Sekisui Medical Co., Ltd., and BioServUK Ltd. These companies are focusing on strategic collaborations, new product launches, and expansion into emerging markets to gain competitive advantage.

Scope of Work – Global Pepsinogen Test Kit Market

Report Metric Details

Market Size (2023) USD 690 million

Projected Market Size (2031) USD 1.18 billion

CAGR (2023–2031) 7.0%

Market Segments System Type, End-use, Region

Growth Drivers Rising gastric disorders, focus on early cancer detection, aging population

Opportunities Emerging market penetration, integration with digital diagnostics

Key Market Developments

2023: Biohit Oyj introduced a new generation of quantitative pepsinogen test kits integrated with digital reporting features to enhance diagnostic accuracy.

2024: Eiken Chemical Co., Ltd. expanded its production capacity in Japan to meet the increasing domestic and international demand for gastric screening products.

2025: Abbott Laboratories announced a strategic collaboration with a major telehealth provider to deploy pepsinogen PoC test kits across remote healthcare centers in Southeast Asia.

FAQs

1. What is the current market size of the Global Pepsinogen Test Kit Market?

The market was valued at USD 690 million in 2023.

2. What is the major growth driver of the Global Pepsinogen Test Kit Market?

The major driver is the rising prevalence of gastric disorders and increased emphasis on early cancer detection.

3. Which is the largest region during the forecast period in the Global Pepsinogen Test Kit Market?

Asia-Pacific is expected to remain the largest region due to robust screening programs and healthcare awareness.

4. Which segment accounted for the largest market share in Global Pepsinogen Test Kit Market?

Laboratory-Based Pepsinogen Test Kits held the largest market share in 2023.

5. Who are the key market players in the Global Pepsinogen Test Kit Market?

Key players include Eiken Chemical Co., Ltd., Biohit Oyj, Abbott Laboratories, and Zhejiang Orient Gene Biotech Co., Ltd.